of copper (Cu) and ceruioplasmin in serum were measured senaliy in 49 preterm infants with mean (± SEM) birth weights of 979 ± 33 g and gestational ages of 28.4 ± 0.3 weeks at three, six, nine, and 12 months postpartum. Serial radiographic studies showed 17 infants with (group A) and 32 infants without (group B) rickets or fractures. Cu and ceruloplasmin concentrations in serum also were measured in 21 healthy term infants (group C) with birth weights 3668 ±989 at three, six, and 12 months postpartum. Analyses of covanance of serial changes in these serum variables-taking into account SUChpotential covanates as differences in gestational age, birth weight, initial weight and length, changes in weight and length during the study, the duration of parenteral nutrition, and increased enteral copper intake-showed both groups of pretemi infants had significantly lower concentrations of Cu in serum up to age six months and cerulopiasmin up to age three months (P <0.001) when compared with term infants. By one year of age, Cu and ceruloplasmin concentrations in serum in all groups had increased significantly (P <0.001), into the adult range, and were not significantly different among groups. These data document a maturational lag in copper metabolism in small, preterm infants. Changes in concentrations of Cu and ceruloplasmin in serum were significantly correlated (r = 092, P <0.001) but were not significantly different between preterm infants with and without rickets or fractures at each age. 
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One longitudinal study of infants with various degrees of prematurity showed that Cu concentrations in serum increase after birth and reach adult values by about six months postpartum; in some instances, by the age of one year these exceed adult values (8) . However, there are no data on the serial changes of Cu concentrations in serum in small, preterm infants beyond the first three months postpartum. Data are also lacking on changes in serum concentrations of ceruloplasmin, an a2-glycoprotein that is the primary carrier for Cu in the circulation (9, 10) . In our study, we documented the serial changes in Cu and ceruloplasmin concentrations in serum in small preterm and term infants during the first year after birth, and tested two hypotheses about Cu and ceruloplasmin concentrations in serum: (a) They are lowest in very-low-birth-weight (<1500 g, VLBW) infants who display radiographic changes consistent with osteopenia and R/F and are in the intermediate range in VLBW infants without R/F when compared with healthy term infants at the same postnatal age, and (b) these values tend to converge in the three groups as postnatal age increases.
Materials and Methods

Subjects and Procedures
Forty-nine VLBW infants with mean (± SEM) birth weights of 979 ± 33 g and gestationalages of 28.4 ± 0.3 weeks were the subjects of the present study. Serial radiographic studies were used to document the presence (group A, n = 17) or absence (group B, n = 32) of R/F at three-month intervals during the first year postpartum. The initial radiographs were made at ages three and six months because of previous reports of the occurrence of R/F between these ages (1-3). All screening radiographs and radiographs taken for clinical purposes were reviewed for R/F, based on previously described criteria (1, 3) . Radiographic abnormalities included four infants with fractures, six infantswith rickets, and seven infants with rickets and fractures. No new skeletal abnormalities were noted at or after the screening radiograph taken at six months, and all cases of R/F were healed by age 12 months. Details of clinical and radiographic changes are presented elsewhere (3). None of the investigators knew the skeletal radiographic status of the infants before enrollment in the study, and radiographs were reviewed without knowledge of the biochemical data. In addition, 21 healthy term infants (group C) with birthweights of 3668 ± 98 g were enrolledin this study. Radiographic study was not performed for term infants.
Blood samples were collected at three-month intervals on four occasions in VLBW infants and at three, six, and 12 months postpartum in term infants. All infants were clinically stable at the time of assessment, and no visible hemolysis was noted in any serum samples. Needles, syringes, and storage containers were checked at random and were free of detectable Cu. Serum samples were stored at -70 #{176}C and measured for Cu and ceruloplasmin in batches. The technician who performed the biochemical measurements was unaware of the group to which the infant was assigned.
We measured the Cu concentration in serum by fiameless atomic absorption spectrophotometry, using a Model 5000 with HGA 500 graphite furnace 
Statistical Methods
Cu and ceruloplasmin concentrations in serum and the postnatal ages at each blood sampling were transformed to their natural logarithm to account for deviations from linearity in the serial determinations and alsoto approximately normalize these statistical distributions. Serial changes with age for each serum variable were estimated for each infant by random coefficient regression analyses (14, 15) . Analyses of covariance were used to determine whether differences in the serial changes of Cu concentrations in serum among groups were significant. These analyses took into account potential covariates, including differences in gestational age, birth weight, initial weight and length, changes in weight and length during study, the duration of PN, increased enteral Cu intake, and a term for interacting gestational age and R/F status. The relationship between serum Cu and ceruloplasmin was estimated by a linear-regression model. Statistical analyses were performed by using the CLINFO program of the National Institutes of Health, General Clinical Research Center, and the University of Cincinnati Computer Center Amdahl 5880 mainframe computer. Unless otherwise stated, all values are given as mean ± SEM. Statistical significance was based on a P value of 0.05 for each estimated value.
Results
At the onset of study, Cu concentrations in serum in VLBW infants with and without R/F were similar, and both groups of VLBW infants had lower Cu concentrations in serum than did term infants (P <0.001); for ceruloplasmin concentrations the relationship among groups was the same as for Cu (Table 1) . Very low concentrations of Cu in serum were found only at age three months in two infants with R/F (5.3 and 5.5 pmol/L) and in three infants without R/F (5.2, 5.8, and 6.1 mol/L). Correlating with the very low Cu concentrations in serum were low ceruloplasmin concentrations in serum: 0.45 and 0.37 jmol/L, respectively, for (26) 2.84 ± 0.15 (26) . C 1.49 ± 0.lOe (11) 1.94 ± 0.13 (11) 2.46 ± 0.10 (12) Group A = VLBW infants with rickets/fractures, Group B = VLBW infants without rickets/fractures, Group C = term infants. bMean ± SEM.
C Number in parentheses = number of infants. d Serum copper and ceruloplasmin increased significantly with postnatal age for each group: P <0.001 (random coefficient regression).
Significantly higher than for other groups at the same postnatal age: P <0.001 (by analyses of covanance).
Copper: 1 mol/L = 6.36 g/dL; ceruloplasmin: 1 p.rnol/L 13.4 mg/dL. p.mol/L, respectively, for the three infants without R/F. With increasing postnatal age, Cu and ceruloplasmin concentrations in serum increased significantly (P <0.001) in all groups but were no longer significantly different between groups by the age of one year (Table  1) . The changes in Cu in serum were correlated with changes in ceruloplasmin concentrations in serum throughout the study (r = 0.92, P <0.001). None of the potential covariates for Cu and ceruloplasmin concentrations in serum that we entered into the analyses was statistically significant.
Discussion
With the availability of graphite-furnace atomic absorption spectrophotometry in clinical medicine, concentr.ations of various trace metals, including Cu, are being measured in serum with increasing frequency in the evaluation of patients with metabolic bone disease. Data are available on changes of Cu concentrations in serum during early infancy (7, 8, (16) (17) (18) (19) (20) (21) (22) , but few reports have provided serial data beyond six months postpartum (8, 20, 22) . Cu concentrations in serum for preterm infants were reported in only one series (8) of infants, whose birth weights were about twice those of the subjects in our study. Our data therefore may be useful in the interpretation of Cu concentration in serum from small preterm infants.
We found that at three months postpartum, the Cu concentrations in serum of VLBW infants were significantly lower than those from infants born at term, a finding consistent with the data in the literature (7, 8, (16) (17) (18) . Grouping the infants by R/F status (present vs absent) and birth weights (<1500 g vs >1500 g) minimized any effect attributable to gestational ages. That is, any effect that might be attributable to gestational age is represented in this study by the factors R/F status and birth weight. The three-month difference in mean gestational ages between the VLBW infants and term infants is reflected by an approximate three-month lag in both Cu and ceruloplasmin concentrations in serum in VLBW infants as compared with those in infants born at term. Therefore, our data support reports that Cu concentrations in serum are related to gestational age (7, 16) , at least for the first few months after birth.
Consistent with reports in the literature for preterm (7, 8, (16) (17) (18) and term (19) (20) (21) (22) infants, our data demonstrated a significant postnatal increase in Cu concentrations in serum. Regardless of the infants' gestational ages, the Cu concentrations in serum increased significantly from about two months after birth (7, 8, (16) (17) (18) (19) (20) 22 ) and reached adult values by late infancy (8, 20, 22) . Variation in the Cu content of infant milk formula does not influence Cu concentrations in serum in preterm (18) or term (19, 22) infants. Copper in human milk appears to be better absorbed than that contained in infant milk formulas (23, 24 Our data showed that serial concentrations of Cu in serum were similar in VLBW infant groups studied at each postnatal age, regardless of the radiographically determined skeletal status and whether the blood samples were obtained during acute or healing phases of bone abnormalities.
Furthermore, none of the infants in this study had the extremely low Cu concentrations in serum (<4.7 pinol/L) found in infants with typical Cu deficiency states (5) (6) (7) , presumably because of the relatively brief period of administering Cu-containing PN solutions and the early attempts at enteral feeding for our patients.
It is not surprising that concentrations of ceruloplasmm and Cu in serum are highly correlated, because ceruloplasmin is the primary carrier for Cu in the circulation (6, 7) . At the beginning of this study the mean ceruloplasmin concentrations in serum in all CLINICAL CHEMISTRY, Vol. 37, No. 4, 1991 559 infants were below the adult reference range and were lower in preterm infants than in term infants. However, ceruloplasmin concentrations in serum increased with postnatal age in all infant groups and were similar to adult values by the age of one year. These trends are consistent with other reports based on colorimetric (16, 17) and immunodiffusion (20, 22) measurements of ceruloplasmin. Our data therefore support the thesis that infants, particularly preterm infants, have a maturational lag in the hepatic synthesis of ceruloplasmin.
We conclude that Cu and ceruloplasmin concentrations in serum in VLBW infants during the acute and healing phases of metabolic bone disease are similar and cannot be used to distinguish between infants with and without radiographic skeletal abnormalities. Our data make it difficult to support the presence of overt Cu deficiency in VLBW infants with R/F. However, because small preterm infants have low body stores of Cu at birth (28) and have high demands for copper during the period of rapid postnatal growth (29), one should not dismiss Cu deficiency as a nutritional problem that may potentially lead to metabolic bone disease.
